US Stock MarketDetailed Quotes

XBIO Xenetic Biosciences

Watchlist
  • 4.0126
  • +0.0226+0.57%
Close Nov 21 16:00 ET
6.19MMarket Cap-1508P/E (TTM)

Xenetic Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-30.04%6.84M
-31.95%7.3M
-34.77%7.82M
-31.41%8.98M
-31.41%8.98M
-29.41%9.78M
-28.15%10.73M
-25.76%11.99M
-28.21%13.1M
-28.21%13.1M
-Cash and cash equivalents
-30.04%6.84M
-31.95%7.3M
-34.77%7.82M
-31.41%8.98M
-31.41%8.98M
-29.41%9.78M
-28.15%10.73M
-25.76%11.99M
-28.21%13.1M
-28.21%13.1M
Receivables
----
--716.38K
----
----
----
----
----
----
----
----
-Accounts receivable
----
--716.38K
----
----
----
----
----
----
----
----
Other current assets
-87.30%188.09K
----
-37.02%552.04K
8.58%603.83K
8.58%603.83K
--1.48M
--1.32M
--876.54K
--556.09K
--556.09K
Total current assets
-37.57%7.03M
-33.46%8.01M
-34.93%8.38M
-29.78%9.59M
-29.78%9.59M
-20.54%11.26M
-21.67%12.04M
-23.79%12.87M
-27.08%13.65M
-27.08%13.65M
Non current assets
Other non current assets
44.56%1.02M
44.56%1.02M
20.60%1.02M
-4.55%1.02M
-4.55%1.02M
-49.89%704.43K
-35.49%704.43K
-22.87%844.43K
-2.29%1.07M
-2.29%1.07M
Total non current assets
44.56%1.02M
44.56%1.02M
20.60%1.02M
-4.55%1.02M
-4.55%1.02M
-49.89%704.43K
-35.49%704.43K
-22.87%844.43K
-2.29%1.07M
-2.29%1.07M
Total assets
-32.73%8.05M
-29.15%9.03M
-31.51%9.39M
-27.96%10.61M
-27.96%10.61M
-23.19%11.96M
-22.58%12.75M
-23.73%13.72M
-25.71%14.72M
-25.71%14.72M
Liabilities
Current liabilities
Payables
-45.75%243.34K
28.16%283.59K
-18.79%210.48K
-16.19%240.83K
-16.19%240.83K
121.21%448.56K
-53.19%221.28K
-7.66%259.18K
-20.72%287.36K
-20.72%287.36K
-accounts payable
-45.75%243.34K
28.16%283.59K
-18.79%210.48K
-16.19%240.83K
-16.19%240.83K
121.21%448.56K
-53.19%221.28K
-7.66%259.18K
-20.72%287.36K
-20.72%287.36K
Current accrued expenses
23.57%766.06K
100.61%1.3M
-15.27%506.01K
-27.62%568.75K
-27.62%568.75K
-26.90%619.94K
-19.40%650.03K
-23.69%597.19K
-23.83%785.8K
-23.83%785.8K
Current liabilities
-5.53%1.01M
82.21%1.59M
-16.33%716.49K
-24.56%809.59K
-24.56%809.59K
1.68%1.07M
-31.89%871.32K
-19.46%856.37K
-24.48%1.07M
-24.48%1.07M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-5.53%1.01M
82.21%1.59M
-16.33%716.49K
-24.56%809.59K
-24.56%809.59K
1.68%1.07M
-31.89%871.32K
-19.46%856.37K
-24.48%1.07M
-24.48%1.07M
Shareholders'equity
Share capital
-22.30%3.35K
-22.32%3.35K
-81.36%3.35K
-22.03%3.35K
-22.03%3.35K
-74.82%4.31K
-74.82%4.31K
10.62%17.97K
-73.56%4.29K
-73.56%4.29K
-common stock
0.59%1.55K
0.52%1.54K
-89.84%1.54K
1.58%1.54K
1.58%1.54K
-89.29%1.54K
-89.29%1.54K
12.81%15.19K
-88.71%1.52K
-88.71%1.52K
-Preferred stock
-34.97%1.8K
-34.97%1.8K
-34.97%1.8K
-34.97%1.8K
-34.97%1.8K
0.00%2.77K
0.00%2.77K
0.00%2.77K
0.00%2.77K
0.00%2.77K
Retained earnings
-2.12%-196.14M
-2.46%-195.7M
-2.35%-194.43M
-2.19%-193.23M
-2.19%-193.23M
-2.37%-192.06M
-2.25%-191.01M
-3.16%-189.96M
-3.59%-189.1M
-3.59%-189.1M
Paid-in capital
0.11%208.2M
0.13%208.17M
0.15%208.13M
0.14%208.05M
0.14%208.05M
0.40%207.98M
0.43%207.91M
0.85%207.83M
0.88%207.77M
0.88%207.77M
Less: Treasury stock
0.00%5.28M
0.00%5.28M
0.00%5.28M
0.00%5.28M
0.00%5.28M
0.00%5.28M
0.00%5.28M
0.00%5.28M
0.00%5.28M
0.00%5.28M
Gains losses not affecting retained earnings
0.00%253.73K
0.00%253.73K
0.00%253.73K
0.00%253.73K
0.00%253.73K
0.00%253.73K
0.00%253.73K
0.00%253.73K
0.00%253.73K
0.00%253.73K
Total stockholders'equity
-35.40%7.04M
-37.31%7.45M
-32.52%8.68M
-28.22%9.8M
-28.22%9.8M
-24.99%10.89M
-21.80%11.88M
-24.00%12.86M
-25.81%13.65M
-25.81%13.65M
Total equity
-35.40%7.04M
-37.31%7.45M
-32.52%8.68M
-28.22%9.8M
-28.22%9.8M
-24.99%10.89M
-21.80%11.88M
-24.00%12.86M
-25.81%13.65M
-25.81%13.65M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -30.04%6.84M-31.95%7.3M-34.77%7.82M-31.41%8.98M-31.41%8.98M-29.41%9.78M-28.15%10.73M-25.76%11.99M-28.21%13.1M-28.21%13.1M
-Cash and cash equivalents -30.04%6.84M-31.95%7.3M-34.77%7.82M-31.41%8.98M-31.41%8.98M-29.41%9.78M-28.15%10.73M-25.76%11.99M-28.21%13.1M-28.21%13.1M
Receivables ------716.38K--------------------------------
-Accounts receivable ------716.38K--------------------------------
Other current assets -87.30%188.09K-----37.02%552.04K8.58%603.83K8.58%603.83K--1.48M--1.32M--876.54K--556.09K--556.09K
Total current assets -37.57%7.03M-33.46%8.01M-34.93%8.38M-29.78%9.59M-29.78%9.59M-20.54%11.26M-21.67%12.04M-23.79%12.87M-27.08%13.65M-27.08%13.65M
Non current assets
Other non current assets 44.56%1.02M44.56%1.02M20.60%1.02M-4.55%1.02M-4.55%1.02M-49.89%704.43K-35.49%704.43K-22.87%844.43K-2.29%1.07M-2.29%1.07M
Total non current assets 44.56%1.02M44.56%1.02M20.60%1.02M-4.55%1.02M-4.55%1.02M-49.89%704.43K-35.49%704.43K-22.87%844.43K-2.29%1.07M-2.29%1.07M
Total assets -32.73%8.05M-29.15%9.03M-31.51%9.39M-27.96%10.61M-27.96%10.61M-23.19%11.96M-22.58%12.75M-23.73%13.72M-25.71%14.72M-25.71%14.72M
Liabilities
Current liabilities
Payables -45.75%243.34K28.16%283.59K-18.79%210.48K-16.19%240.83K-16.19%240.83K121.21%448.56K-53.19%221.28K-7.66%259.18K-20.72%287.36K-20.72%287.36K
-accounts payable -45.75%243.34K28.16%283.59K-18.79%210.48K-16.19%240.83K-16.19%240.83K121.21%448.56K-53.19%221.28K-7.66%259.18K-20.72%287.36K-20.72%287.36K
Current accrued expenses 23.57%766.06K100.61%1.3M-15.27%506.01K-27.62%568.75K-27.62%568.75K-26.90%619.94K-19.40%650.03K-23.69%597.19K-23.83%785.8K-23.83%785.8K
Current liabilities -5.53%1.01M82.21%1.59M-16.33%716.49K-24.56%809.59K-24.56%809.59K1.68%1.07M-31.89%871.32K-19.46%856.37K-24.48%1.07M-24.48%1.07M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities -5.53%1.01M82.21%1.59M-16.33%716.49K-24.56%809.59K-24.56%809.59K1.68%1.07M-31.89%871.32K-19.46%856.37K-24.48%1.07M-24.48%1.07M
Shareholders'equity
Share capital -22.30%3.35K-22.32%3.35K-81.36%3.35K-22.03%3.35K-22.03%3.35K-74.82%4.31K-74.82%4.31K10.62%17.97K-73.56%4.29K-73.56%4.29K
-common stock 0.59%1.55K0.52%1.54K-89.84%1.54K1.58%1.54K1.58%1.54K-89.29%1.54K-89.29%1.54K12.81%15.19K-88.71%1.52K-88.71%1.52K
-Preferred stock -34.97%1.8K-34.97%1.8K-34.97%1.8K-34.97%1.8K-34.97%1.8K0.00%2.77K0.00%2.77K0.00%2.77K0.00%2.77K0.00%2.77K
Retained earnings -2.12%-196.14M-2.46%-195.7M-2.35%-194.43M-2.19%-193.23M-2.19%-193.23M-2.37%-192.06M-2.25%-191.01M-3.16%-189.96M-3.59%-189.1M-3.59%-189.1M
Paid-in capital 0.11%208.2M0.13%208.17M0.15%208.13M0.14%208.05M0.14%208.05M0.40%207.98M0.43%207.91M0.85%207.83M0.88%207.77M0.88%207.77M
Less: Treasury stock 0.00%5.28M0.00%5.28M0.00%5.28M0.00%5.28M0.00%5.28M0.00%5.28M0.00%5.28M0.00%5.28M0.00%5.28M0.00%5.28M
Gains losses not affecting retained earnings 0.00%253.73K0.00%253.73K0.00%253.73K0.00%253.73K0.00%253.73K0.00%253.73K0.00%253.73K0.00%253.73K0.00%253.73K0.00%253.73K
Total stockholders'equity -35.40%7.04M-37.31%7.45M-32.52%8.68M-28.22%9.8M-28.22%9.8M-24.99%10.89M-21.80%11.88M-24.00%12.86M-25.81%13.65M-25.81%13.65M
Total equity -35.40%7.04M-37.31%7.45M-32.52%8.68M-28.22%9.8M-28.22%9.8M-24.99%10.89M-21.80%11.88M-24.00%12.86M-25.81%13.65M-25.81%13.65M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data